Lebanon vs Pakistan: The number of people with susceptibility test result for rifampicin
Lebanon
91.2
in 2021
Pakistan
91.93
in 2021
Lebanon rank
66th
Pakistan rank
63rd
The number of people with susceptibility test result for rifampicin over time
- Lebanon
- Pakistan
How they compare
Pakistan currently reports 91.93 against 91.2 in Lebanon, a difference of 0.73.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Lebanon ahead.
Lebanon ranks 66th and Pakistan ranks 63rd of 146 countries.
Lebanon has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lebanon | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 92.21 | 43.98 | 48.24 | Lebanon |
| 2020s | 92.99 | 81.25 | 11.74 | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Lebanon or Pakistan?
- Pakistan, at 91.93 against 91.2 in Lebanon as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Lebanon and Pakistan?
- 0.73, with Pakistan ahead.
- How many years of comparable data are there for Lebanon and Pakistan?
- 5 years are reported by both, from 2017 to 2021.
- How do Lebanon and Pakistan rank globally for the number of people with susceptibility test result for rifampicin?
- Lebanon ranks 66th and Pakistan ranks 63rd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.